Skip to content
GERICLINICS

GeriQBank · Paper IV · Q3

Nutritional Assessment in Older Persons

High YieldAsked ×27-mark note
Chapter
Nutrition in the Elderly
Years asked
Not recorded in the source
Frequency
Set 2× in Paper IV (2009–2025)

As set in the university paper

  • Nutritional assessment in older persons.

    Paper IV · Nutrition, Sarcopenia & Frailty · asked ×2 · 7-mark note · see in paper list

Answer framework

  1. Concept and framework — the four questions; why no single parameter works; screen, diagnose, grade
  2. Screening tools — MNA and MNA-SF; MNA domains and performance; SGA, MUST, NRS-2002, GNRI; SNAQ; the routine screening question
  3. Diagnosis by GLIM — phenotypic and etiologic criteria; Stage 1 and Stage 2; caution with BMI alone
  4. Full assessment — history; examination and dental screen; anthropometry and its pitfalls; body composition; function; biochemistry; dietary intake and CGA; monitoring
  5. Recent updates — GLIM 5-year update; validated calf and arm circumference; prevalence depends on the tool; GLIS 2024; phase angle, BIVA and ultrasound; ESPEN screening; Indian BMI cut-offs; ICMR-NIN 2024

An exam answer plan drawn from the detailed answer below. Use it to attempt the question first.

Detailed answer

Pro · free in beta
Attempt it firstOutline your answer as a 7-mark note before revealing it — definition, causes, evaluation, management and the geriatric angle.Reveal answer

Short revision answer

  • Nutritional assessment asks: is malnutrition suspected, of which nutrients and how much, by what mechanism, and why? No single parameter suffices in older people, so assess across domains: SCREEN (MNA-SF) → DIAGNOSE (GLIM) → GRADE severity and mechanism.
  • MNA-SF: 12–14 normal, 8–11 at risk, 0–7 malnourished. Domains: intake and weight loss over 3 months, mobility, acute stress, dementia or depression, and BMI (or calf circumference <31 cm). MNA is 96% sensitive and 60% specific — a screen, not a diagnosis — and a normal MNA predicts lower mortality.
  • Other tools: SGA, MUST, NRS-2002 and GNRI; SNAQ covers appetite, satiety, taste and meals (<14 = risk of weight loss). In routine review ask "Have you lost weight?", record height and weight, and use MEALS ON WHEELS to find treatable causes.
  • GLIM needs ≥1 phenotypic criterion (weight loss >5% in 6 months or >10% beyond 6 months; low BMI — in Asia <18.5 if <70 y, <20 if >70 y; reduced muscle mass) plus ≥1 etiologic criterion (reduced intake or absorption, or inflammation). Stage 2 (severe) = >10% loss in 6 months. Never diagnose on low BMI alone.
  • History: rate of weight loss (5% in 1 month, 7.5% in 3 months or 10% in 6 months is serious), appetite, chewing and swallowing, diet, alcohol, drugs (>250 alter taste), mood, cognition and social circumstances. Examination: wasting, mouth and dentures, swallowing, faecal impaction, pressure ulcers and deficiency signs; a dental screening score ≥3 warrants referral.
  • Anthropometry: weight = global status; BMI = total fat; skinfolds = percentage fat; mid-arm circumference = lean mass (the measure of choice in oedema); calf <31 cm = low muscle. Prefer serial weight to BMI (kyphosis distorts height); estimate height from knee height. BMI <22 predicts higher one-year mortality.
  • Body composition: DXA, BIA, CT at L3 or MRI (FFMI <17 men, <15 women); otherwise calf or mid-arm circumference. Function — grip, gait speed, TUG, SPPB — tracks outcome better than mass.
  • Biochemistry: exclude liver disease, proteinuria and gut losses before reading albumin (now regarded as an inflammatory, not nutritional, marker); anaemia is an early sign; lymphocyte count; CRP separates starvation (<3 mg/L) from hypercatabolism (>100 mg/L); B12, folate, vitamin D, ferritin, TSH. Intake records suffer recall bias, worse with cognitive impairment. Weigh care-home residents monthly.
  • Updates: the GLIM 5-year update (2025) kept the criteria and grading; calf <31 cm or MUAC <23 cm (men)/<22 cm (women) are now validated against SGA (accuracy >83%); prevalence is 18.6% overall but 39.9% with NRS-2002 — always name the tool. GLIS 2024 makes physical performance an outcome, not a component, of sarcopenia.
  • Phase angle, BIVA and muscle ultrasound are emerging bedside tools; ESPEN says all older persons shall be screened. India: LASI-based underweight cut-offs fall to <17.4 (60–74) and <13.3 (75 and above); 28% of men and 25% of women aged 60+ are underweight; ICMR-NIN 2024 sets safe protein at 0.83 g/kg/day and discourages protein supplements.

Condensed by GeriClinics from the detailed answer below, with no new facts added.

15 marks · Source: Pathy’s 6th ed. (Ch. 12, 13, 14, 16 and Function Assessment Scales appendix); Essentials of Clinical Geriatrics 7th ed. (Ch.

3, Tables 3-11 to 3-14)

20 High-Yield Points

CONCEPT AND FRAMEWORK

1.

Purpose. Nutritional assessment answers four questions (Essentials, Table 3-12): Is there reason to suspect malnutrition? Of which nutrient(s) and to what extent? What is the pathophysiological mechanism? What is the underlying etiology?

2.

Why assessment is different in the elderly. No single parameter is adequate — anthropometric variables are not highly correlated with biochemical or haematologic indicators, and the effect of ageing on lean body mass is so great that lean mass alone is a poor reflection of nutritional status. Assessment must therefore be multi-parameter and multi-domain.

3.

The standard two-step (now three-step) approach. Step 1 — SCREEN every older person with a validated tool. Step 2 — DIAGNOSE using GLIM criteria. Step 3 — GRADE severity and identify the mechanism, then plan intervention.

STEP 1 — SCREENING TOOLS

4.

Mini Nutritional Assessment (MNA) — the geriatric standard. The full MNA is multidimensional and identifies malnourished elders or those at risk, whatever the cause. MNA-SF has equivalent performance: 12– 14 = normal, 8–11 = at risk, 0–7 = malnourished. Body mass is entered as BMI (0 = <19, 1 = 19–20.9, 2 = 21– 22.9, 3 = ≥23) or, if BMI is unavailable, calf circumference (0 = <31 cm, 3 = ≥31 cm).

5.

MNA components (six domains). (A) decline in food intake over 3 months, (B) weight loss over 3 months, (C) mobility, (D) psychological stress or acute illness in 3 months, (E) neuropsychological problems (dementia/depression), (F) BMI or calf circumference.

6.

Performance and prognostic value. MNA is 96% sensitive and 60% specific for body weight loss. Subjects with a normal MNA had lower mortality (RR 0.35, 95% CI 0.18–0.66) than those with an abnormal score. Those “at risk” had more acute illness, more assistance needs and more weight loss. MNA is a powerful independent prognostic factor, especially in cancer, and can assess cancer cachexia. A six-item version has equivalent predictive value.

7.

Other validated tools. SGA (predicts mortality but classifies more patients as well-nourished than MNA — those “well-nourished” by MNA had better 3-year survival), MUST, NRS-2002, and the Geriatric Nutritional Risk Index (GNRI), which predicts healthcare costs and hospitalisation.

8.

SNAQ (Simplified Nutritional Appetite Questionnaire) — four questions on appetite, early satiety, taste of food, and number of meals per day, each scored 1–5. A score <14 indicates significant risk of weight loss. Recommended by Pathy’s as a rapid appetite screen.

9.

Screening question in routine geriatric review (Pathy’s Function Assessment Scales): ask “Have you lost weight?” and record height and weight; if positive, proceed to BMI, MNA, SNAQ, and use the “MEALS ON WHEELS” mnemonic to look for treatable causes.

STEP 2 — DIAGNOSIS BY GLIM

10.

GLIM criteria — malnutrition requires ≥1 phenotypic + ≥1 etiologic criterion:

Phenotypic Etiologic

Weight loss >5% in 6 months or >10% beyond 6 months Reduced food intake — ≤50% of energy requirement for >1 week, any reduction for >2 weeks, or any chronic GI condition impairing assimilation/absorption Low BMI — <20 if <70 y, <22 if >70 y; Asia: <18.5 if <70 y, <20 Inflammation — acute disease/injury or chronic disease-if >70 y related Reduced muscle mass — by validated body-composition technique; where unavailable, mid-arm muscle or calf circumference; handgrip strength as a supportive measure

11.

Severity grading (GLIM Stage 1 vs Stage 2). Stage 1 (moderate): weight loss 5–10% in 6 months or 10–20% beyond 6 months; BMI <20 if <70 y, <22 if ≥70 y; mild–moderate muscle deficit. Stage 2 (severe): weight loss >10% in 6 months or >20% beyond 6 months; BMI <18.5 if <70 y, <20 if ≥70 y; severe muscle deficit.

12.

Caution. Diagnosing malnutrition on low BMI alone, without identifying a cause, overestimates prevalence. Always pair a phenotypic with an etiologic criterion. Nutrition in the Elderly — MD Geriatric Medicine Revision Page 11 of 25 STEP 3 — COMPONENTS OF FULL ASSESSMENT

13.

History. Weight history (magnitude and rate of loss — 5% in 1 month, 7.5% in 3 months, 10% in 6 months is serious), appetite (SNAQ), chewing and swallowing difficulty, dietary history, food fads and restrictive diets, alcohol, drug review (>250 drugs alter taste), depression, dementia, social and financial circumstances, ability to shop and cook, living alone.

14.

Physical examination. General appearance and muscle wasting; oral examination — dentition, ill-fitting dentures, xerostomia, candidiasis, dental plaque, loss of occluding pairs; swallowing test; abdominal exam for faecal impaction; skin for pressure ulcers and poor wound healing; Braden scale for pressure-ulcer risk; signs of specific deficiencies (glossitis, cheilosis, neuropathy, ataxia, ecchymoses, oedema). Pathy’s dental screening tool: dry mouth (2), eating difficulty (1), no dental care within 2 years (1), tooth/mouth pain (2), change in food selection (1), oral lesions (2) — ≥3 points warrants dental referral.

15.

Anthropometry — what each measure reflects (Essentials, Table 3-11):

Measure Reflects

Weight Global nutritional status

BMI Total body fat

Triceps and subscapular skinfolds Percentage body fat Waist–hip ratio Central adiposity Upper-arm (mid-arm) circumference Lean body mass — particularly useful in oedematous patients where weight misleads Calf circumference (<31 cm) Low muscle mass surrogate

16.

Practical anthropometric pitfalls and corrections. Serial weight is preferred to BMI — kyphosis makes height unreliable; also consider oedema. Height from knee height: Men = (2.02 × knee height cm) − (0.04 × age) + 64.19; Women = (1.83 × knee height cm) − (0.24 × age) + 84.88. Amputee weight corrections: single below-knee 6%, at knee 9%, above knee 15%, single arm 6.5%, arm below elbow 3.6%. BMI <22 kg/m² predicts higher one-year mortality; BMI below the 15th percentile independently predicts 180-day post-hospitalisation mortality.

17.

Body composition and muscle assessment. DXA (fat-free mass index, appendicular lean mass index), BIA, CT at the L3 slice (muscle index, used in cancer follow-up), MRI. GLIM/sarcopenia cut-offs: FFMI <17 (men), <15 (women) kg/m²; ASMI <7.0 (men), <5.4–5.7 (women) kg/m². Where these are unavailable, calf circumference or MAMC is acceptable.

18.

Functional assessment (increasingly the anchor). Handgrip strength, gait speed, Timed Up and Go, unipodal stance, chair rise, and SPPB (predicts disability). Function correlates with outcome better than mass alone.

19.

Biochemical assessment. Serum albumin — practical, but liver disease, proteinuria and protein-losing enteropathy must be excluded; a normal or raised albumin does not exclude malnutrition. Prealbumin (thyroxine-binding) and retinol-binding protein are more sensitive than albumin and transferrin. Haemoglobin — anaemia is one of the earliest manifestations of protein-calorie malnutrition. Total lymphocyte count — a good marker of nutritional problems. CRP — grades inflammation and separates starvation (CRP <3 mg/L) from cachexia (medium grade) and hypercatabolism (CRP >100 mg/L). Micronutrients: B12 with MMA and homocysteine, folate (red-cell folate reflects the preceding 120 days), 25(OH)D, ferritin with CRP, calcium, TSH. Zinc measurement is unreliable — cytokines lower serum zinc; leukocyte or hair zinc may help. Also: creatinine clearance, blood count, and targeted cancer screening where weight loss is unexplained.

20.

Dietary intake and multidomain assessment. Intake: 24-hour recall, food-frequency questionnaire, food diary, plate-waste/intake charts. Limitations in elders: recall and misclassification bias, worse with cognitive impairment — hence the value of objective nutrient biomarkers. CGA-based assessment (Pathy’s Table 14.3) — cognition (MMSE/MoCA), depression (GDS), delirium (CAM), Nutrition in the Elderly — MD Geriatric Medicine Revision Page 12 of 25 falls (TUG, SPPB), function (Katz, Barthel, Lawton–Brody), morbidity and drug review, nutrition (BMI, MNA, weight history, swallowing, constipation screen, oral exam), and social/socioeconomic domains. Monitoring: weigh nursing-home residents monthly; persistent weight loss must prompt a search for treatable medical, psychiatric and functional conditions.

Latest Updates (2023–Present)

1.

GLIM — 5-year update. Following review of >400 publications from 2019–2024, no revisions were made to the weight loss, low BMI or reduced food intake/assimilation criteria; assessment of low muscle mass should be guided by experience and available technological resources, and clinical judgement may suffice for the inflammation/disease burden criterion. Severity-grading thresholds are unchanged, but a broad distinction between moderate and severe reduction of muscle mass is not yet possible because only some methods allow that level of differentiation, and further research is needed to secure consensus reference BMI data for Asian populations. (Jensen GL, et al. Clin Nutr / JPEN. 2025.)

2.

Bedside surrogates for muscle mass formally validated. Applying calf circumference <31 cm in both sexes, or MUAC <23 cm in men and <22 cm in women, gave 84.6% and 83.4% accuracy against SGA, with sensitivity ~89% and ~84% and specificity ~81–83%. Directly applicable in Indian wards without DXA or BIA. (Shahraki Jazinaki M, et al.

Front Nutr. 2024;11:1438158.)

3.

Choice of tool changes the answer. A meta-analysis of 98 studies (n = 79,976) found a global malnutrition prevalence of 18.6% (95% CI 16.4–21.1%) in older adults, with the highest prevalence — 39.9% — obtained using NRS-2002. Examination point: always state which instrument was used. (Salari N, et al. Public Health in Practice.

2025;9:100583.)

4.

Sarcopenia assessment reframed — GLIS 2024. Muscle mass, muscle strength and muscle-specific strength were all accepted as components of sarcopenia, whereas impaired physical performance was accepted as an outcome rather than a component. (Kirk B, et al. Age Ageing. 2024;53:afae052.)

5.

BIA phase angle and BIVA — emerging bedside tools. Phase angle is a highly reliable indicator of skeletal muscle quality because it is calculated directly from reactance and resistance and does not depend on an estimation formula. In hospitalised older patients, standardised phase angle carried prognostic significance and BIVA usefully estimated body-composition/nutrition phenotypes; patients with low standardised phase angle had significantly lower BMI and fat mass. BIVA also discriminated sarcopenic from non-sarcopenic elderly in both sexes, supporting 50 kHz phase-sensitive measurements as biomarkers of hydration, catabolic state and nutritional status. (Front Aging / Clin Nutr cohort studies. 2024–2025; Sensors. 2023;23:7090.)

6.

Muscle ultrasound entering nutritional assessment. In hospitalised older adults, ultrasound and bioelectrical impedance analysis are reliable, non-invasive and reproducible for quantitative and qualitative muscle assessment, with rectus femoris cross-sectional area, thickness, echogenicity and compressibility measured combinedly for sarcopenia diagnosis. (Nutrients. 2024;16:2429.)

7.

ESPEN — screening is mandatory, not optional. All older persons shall routinely be screened for malnutrition in order to identify existing risk early. Low-intake dehydration should be diagnosed on the basis of serum osmolality, not clinical signs alone. A dedicated ESPEN update for dementia followed in 2024. (Volkert D, et al. Clin Nutr. 2022;41:958–989; Volkert D, et al. Clin Nutr. 2024.)

8.

Indian BMI cut-offs need adjustment. CART analysis of LASI data lowered the underweight cut-off from <18.5 to <17.4 for ages 60–74 and <13.3 for those 75 and above, based on cardio-metabolic outcomes. Set against LASI prevalence — 28% of men and 25% of women aged 60 and above are underweight, with those from low economic and social strata more likely to be underweight. (Singh A, Chattopadhyay A. Sci Rep. 2024;14:15200; Khan J, et al. Sci Rep.

2023;13:12820.)

9.

Indian dietary reference values for interpreting intake. ICMR-NIN Dietary Guidelines for Indians 2024 with the “My Plate for the Day” model and RDA 2020 (safe protein 0.83 g/kg/day, EAR 0.66 g/kg/day; DIAAS replacing PDCAAS for protein quality). The guidelines discourage protein supplements and high-protein concentrates, citing bone mineral loss and kidney damage with prolonged intake. (ICMR-NIN. Dietary Guidelines for Indians. 2024.)

Current Practice Update

Textbook Position (Pathy’s 2022 / Essentials 7e) Current Evidence-Based Practice (2023–present) “Serum albumin is a practical indicator of malnutrition”; Albumin and prealbumin are now regarded as inflammatory and prealbumin/RBP more sensitive prognostic markers, not nutritional markers, and are excluded from GLIM; CRP is used only to grade inflammation Muscle mass measurement “difficult in routine practice”; calf Calf circumference <31 cm and MUAC <23 cm (M) / <22 cm (F) circumference proposed as a surrogate now have formal validation data (accuracy >83% vs SGA); GLIM 2025 explicitly permits whatever method is locally available GLIM presented as a newly published consensus (2019) GLIM 5-year update 2025 — criteria confirmed, severity grading unchanged, validity established across >400 studies; Asian BMI reference data still awaited Nutrition in the Elderly — MD Geriatric Medicine Revision Page 13 of 25 Sarcopenia assessed by muscle mass + performance (EWGSOP) GLIS 2024 — performance is an outcome, not a component; muscle-specific strength added as a third component Body composition by DXA, BIA, CT, MRI BIA-derived phase angle and BIVA, and muscle ultrasound (rectus femoris CSA, thickness, echogenicity) are emerging as bedside, radiation-free adjuncts with independent prognostic value WHO BMI cut-offs applied to all older adults Asian GLIM cut-offs (<18.5 if <70 y; <20 if >70 y) and Indian LASI-derived cut-offs (2024) perform better in our population Screening described as good practice ESPEN: routine screening of all older persons “shall” be performed — now a standard of care; and the choice of tool materially changes prevalence (NRS-2002 gives the highest estimates)

Examiner’s Tip — Mark-Earning Lines

“Nutritional assessment in the elderly follows a three-step sequence: SCREEN (MNA-SF) → DIAGNOSE (GLIM) → GRADE severity and mechanism (CRP).”

“No single parameter suffices — anthropometric measures correlate poorly with biochemical indices, and ageing alters lean body mass so much that it is a poor marker on its own.”

“MNA-SF: 12–14 normal, 8–11 at risk, 0–7 malnourished; use calf circumference <31 cm when BMI cannot be obtained.”

“MNA is 96% sensitive and 60% specific — a good screen, not a diagnostic test.”

“Severity grading: Stage 1 (moderate) = 5–10% loss in 6 months; Stage 2 (severe) = >10% loss in 6 months.”

“Serial weight, not BMI, is the most reliable anthropometric measure — use knee-height formulae when height cannot be measured.”

“Mid-arm circumference is the measure of choice in oedema, where weight misleads.” “Albumin is an inflammatory marker, not a nutritional marker — the single commonest error in ward practice.”

“Anaemia is one of the earliest manifestations of protein-calorie malnutrition — it should prompt, not follow, nutritional assessment.”

Nutrition in the Elderly — MD Geriatric Medicine Revision Page 14 of 25

How was your recall?

Rating marks the question complete. “Need another pass” also adds it to your bookmarks.

References

Spotted an error or something out of date?Report a problem with this page